198 related articles for article (PubMed ID: 1631902)
1. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase.
Boor PJ; Trent MB; Lyles GA; Tao M; Ansari GA
Toxicology; 1992; 73(3):251-8. PubMed ID: 1631902
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications.
Deng Y; Yu PH
J Chromatogr Sci; 1999 Sep; 37(9):317-22. PubMed ID: 10497785
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Semicarbazide Sensitive Amine Oxidase Activity on Rat Aortic Vascular Smooth Muscle Cells.
Manasieva V; Thakur S; Lione LA; Baydoun AR; Skamarauskas J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902376
[TBL] [Abstract][Full Text] [Related]
4. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta.
Precious E; Gunn CE; Lyles GA
Biochem Pharmacol; 1988 Feb; 37(4):707-13. PubMed ID: 3342102
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of methylamine by semicarbazide-sensitive amine oxidase in white and brown adipose tissue of the rat.
Conforti L; Raimondi L; Lyles GA
Biochem Pharmacol; 1993 Aug; 46(4):603-7. PubMed ID: 8363633
[TBL] [Abstract][Full Text] [Related]
6. Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells.
Hernandez M; Solé M; Boada M; Unzeta M
Biochim Biophys Acta; 2006 Feb; 1763(2):164-73. PubMed ID: 16448709
[TBL] [Abstract][Full Text] [Related]
7. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes.
Yu PH; Zuo DM
Diabetes; 1993 Apr; 42(4):594-603. PubMed ID: 8454111
[TBL] [Abstract][Full Text] [Related]
8. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.
Gubisne-Haberle D; Hill W; Kazachkov M; Richardson JS; Yu PH
J Pharmacol Exp Ther; 2004 Sep; 310(3):1125-32. PubMed ID: 15128865
[TBL] [Abstract][Full Text] [Related]
9. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
Yu PH; Davis BA; Boulton AA; Zuo DM
J Neural Transm Suppl; 1994; 41():397-406. PubMed ID: 7931256
[TBL] [Abstract][Full Text] [Related]
10. Cultured rat vascular smooth muscle cells are resistant to methylamine toxicity: no correlation to semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Boor PJ
Cardiovasc Toxicol; 2001; 1(1):51-60. PubMed ID: 12213997
[TBL] [Abstract][Full Text] [Related]
11. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
Pino R; Lyles GA
Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive effects of methylamine in isolated human blood vessels: role of semicarbazide-sensitive amine oxidase, formaldehyde, and hydrogen peroxide.
Conklin DJ; Cowley HR; Wiechmann RJ; Johnson GH; Trent MB; Boor PJ
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H667-76. PubMed ID: 14715500
[TBL] [Abstract][Full Text] [Related]
13. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities.
Lyles GA; McDougall SA
J Pharm Pharmacol; 1989 Feb; 41(2):97-100. PubMed ID: 2568436
[TBL] [Abstract][Full Text] [Related]
14. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
[TBL] [Abstract][Full Text] [Related]
15. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
16. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover.
Yu PH; Deng YL
Atherosclerosis; 1998 Oct; 140(2):357-63. PubMed ID: 9862279
[TBL] [Abstract][Full Text] [Related]
17. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells.
Mercier N; Moldes M; El Hadri K; Fève B
Biochem J; 2001 Sep; 358(Pt 2):335-42. PubMed ID: 11513731
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes.
Grönvall JL; Garpenstrand H; Oreland L; Ekblom J
Life Sci; 1998; 63(9):759-68. PubMed ID: 9740313
[TBL] [Abstract][Full Text] [Related]
19. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
20. 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase.
Yu PH; Davis BA; Deng Y
Biochem Pharmacol; 2001 Mar; 61(6):741-8. PubMed ID: 11266660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
